Selective Intra-Arterial Lutetium-177-Labeled Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: Initial Results

J Vasc Interv Radiol. 2022 Mar;33(3):342-345. doi: 10.1016/j.jvir.2021.10.016. Epub 2021 Oct 27.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Lutetium
  • Male
  • Neoplasm Metastasis
  • Prostate
  • Prostate-Specific Antigen
  • Prostatic Neoplasms, Castration-Resistant* / diagnostic imaging
  • Radioisotopes
  • Treatment Outcome

Substances

  • Radioisotopes
  • Lutetium
  • Lutetium-177
  • Prostate-Specific Antigen